Near-infrared spectrometer probe monitoring a pharmaceutical process for real-time release testing
Quality & Compliance

Process Analytical Technology and Real-Time Release: Modernizing Quality Control

Biotechnology Media Insights Editorial
Quality & Compliance

Using in-process measurement to shorten release times and strengthen process understanding.

This paper describes how PAT tools, multivariate models and risk-based control strategies enable real-time release testing and reduce reliance on end-product testing.

Quality control in pharmaceutical manufacturing has traditionally relied on sampling finished product and testing it in a laboratory. This approach is slow and provides limited insight into process behavior. Process analytical technology (PAT) offers an alternative: measuring critical attributes during processing, in real time, and using that information to understand and control the process. Combined with a strong control strategy, PAT can support real-time release testing (RTRT), shortening release times and strengthening assurance of quality. This white paper explains the principles, tools and implementation steps.

From Quality by Testing to Quality by Design

Regulatory initiatives, including FDA's PAT framework and ICH Q8, Q9, Q10 and Q11, promote building quality into products through understanding rather than testing it in at the end. Quality by design (QbD) identifies critical quality attributes (CQAs), links them to critical material attributes and process parameters, and establishes a control strategy ensuring that the process consistently delivers product meeting specifications.

The Role of PAT

PAT is a system for designing, analyzing and controlling manufacturing through timely measurement of critical quality and performance attributes. It encompasses analytical tools, multivariate data analysis, process control and knowledge management.

PAT Tools and Technologies

Spectroscopic Methods

Near-infrared, Raman, mid-infrared and UV-visible spectroscopy are non-destructive and fast, and can be implemented in-line, on-line or at-line. Applications include blend uniformity, moisture content during drying, granule properties, coating thickness, API concentration in tablets and cell culture metabolite monitoring.

Other Sensors

Particle size analyzers, focused beam reflectance measurement, acoustic sensors, temperature and pressure probes, and soft sensors that infer variables from other measurements broaden the toolkit. In bioprocessing, in-line probes monitor glucose, lactate, viable cell density and product titer.

Implementation Modes

  • •In-line: sensor is placed directly in the process stream
  • •On-line: sample is diverted automatically to an instrument and may be returned
  • •At-line: sample is removed and measured near the process
  • •Off-line: conventional laboratory testing

Chemometric Modeling

Building Calibration Models

Spectral signals are complex and must be translated into meaningful quality predictions using multivariate techniques such as partial least squares regression. Models are developed using samples covering expected variation in composition and process conditions, paired with reference method results.

Validation and Lifecycle Management

Models should be validated for accuracy, precision, specificity, range and robustness. Over time, raw material changes, equipment wear and process drift can degrade performance. A lifecycle plan defines monitoring, periodic verification and triggers for updating the model, supported by change control.

Multivariate Statistical Process Control

Multivariate control charts monitor the process fingerprint and detect unusual behavior that univariate limits might miss, supporting early intervention.

Real-Time Release Testing

Concept and Requirements

RTRT is the ability to evaluate and ensure the quality of in-process and final product based on process data, typically including a valid combination of assessed material attributes and process controls. A parameter that is released in real time must be justified as equivalent or superior to the conventional test.

Benefits

RTRT reduces release time from days to hours, decreases inventory and laboratory workload, and enables faster response to demand. It also encourages deeper process understanding and tighter control.

Regulatory Expectations

Applications describing RTRT should present the control strategy, model validation, and plans to handle model failures, such as fallback to conventional testing. Early consultation with regulators is recommended. ICH Q8 and Q11 provide principles, and regional guidance on RTRT clarifies expectations.

Control Strategy Design

A robust control strategy integrates input material controls, process parameter controls, in-process controls, PAT measurements and finished product specifications. It is risk-based: high-risk CQAs warrant more comprehensive controls. Documenting the rationale linking each control to a CQA helps both internal teams and reviewers.

Implementation Roadmap

Start With High-Value Opportunities

Select unit operations where real-time information offers clear benefit, such as blending, drying or granulation endpoint detection. Quick wins build momentum and capability.

Build Cross-Functional Teams

Success requires collaboration between process development, analytical science, quality, regulatory, automation and IT. Training ensures that operators and analysts understand the technology.

Infrastructure and Data Management

Reliable data acquisition, secure storage, model management software and integration with manufacturing execution systems are essential. Data integrity controls must cover PAT systems.

Change Control and Continuous Improvement

As more data accumulate, models and control strategies can be refined. Structured change management allows improvements without regulatory surprises.

Common Challenges

Challenges include sensor fouling, representative sampling, model transferability between sites, resistance to change and the effort needed to build initial models. Phased deployment and clear business cases help overcome these hurdles.

Conclusion

PAT and real-time release testing modernize quality control by moving from retrospective testing to proactive, data-driven assurance. Organizations that invest in process understanding, robust models and thoughtful control strategies gain faster release, lower cost and stronger confidence in product quality.

Download This White Paper

Biotechnology Media Insights

Continue to Biotechnology Media Insights to access this white paper.

Pharmaceutical & Biotechnology White Papers | Biotechnology Media Insights